Comprehensive analysis platform to understand, remedy, and eliminate amyotrophic lateral sclerosis (CAPTURE ALS): Study protocol for a Canadian multicenter, multimodal, longitudinal observational study

CAPTURE ALS is a scalable clinical research platform that connects scientists and patients to facilitate efficient translational research. The unique and deeply phenotyped data and biosamples are a global resource towards the development of biomarkers and understanding ALS biology. This study is registered at clinicaltrials.gov (NCT: NCT05204017).

Authors

Institutions

Publication Details

Journal
PLoS ONE
Published
2025-12-04
DOI
https://doi.org/10.1371/journal.pone.0332430
Primary Topic
Amyotrophic Lateral Sclerosis Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Comprehensive analysis platform to understand, remedy, and eliminate amyotrophic lateral sclerosis (CAPTURE ALS): Study protocol for a Canadian multicenter, multimodal, longitudinal observational study

Yasser Iturria‐Medina, Jason Karamchandani, Peter Seres, Simon J. Graham et al.
PLoS ONE
Amyotrophic Lateral Sclerosis Research
article

Comprehensive analysis platform to understand, remedy, and eliminate amyotrophic lateral sclerosis (CAPTURE ALS): Study protocol for a Canadian multicenter, multimodal, longitudinal observational study

Yasser Iturria‐Medina, Jason Karamchandani, Peter Seres, Simon J. Graham, Alan C. Evans, Ekaterina Rogaeva, Fred Tam, David Taylor, HyungMo Kang, Sanjay Kalra, Wendy Johnston, Jasna Križ, Yana Yunusova, Russell Greiner, Angela Genge, Shelagh K. Genuis, Mathieu Blais, Avnit Dhanoa, Lorne Zinman, Agessandro Abrahão, Christine Vande Velde, Kelvin E. Jones, Marie‐Noëlle Boivin, Liziane Bouvier, Gerald Pfeffer, Robert Bowser, Samir Das, Tanushka Anand, Rida Abou-Haidar, Westerly Luth, Janice Robertson, Nicolas Dupré, Claire Magnussen, Natalie Saunders, Tania Bubela, Clémence Tremblay-Desbiens, Nicolas Ferry, Geneviève Matte, Yvonne Frater, Julia Chiappini, Harpreet Bhinder
article en

Abstract

CAPTURE ALS is a scalable clinical research platform that connects scientists and patients to facilitate efficient translational research. The unique and deeply phenotyped data and biosamples are a global resource towards the development of biomarkers and understanding ALS biology. This study is registered at clinicaltrials.gov (NCT: NCT05204017).

PLoS ONEVol. 20(12)
Montreal Neurological Institute and Hospital (CA), Sunnybrook Health Science Centre (CA), Barrow Neurological Institute (US), University of Alberta (CA), University of Calgary (CA), Simon Fraser University (CA), University of Toronto (CA), Multiple Sclerosis Society of Canada (CA), Health Sciences Centre (CA), Alzheimer Society of Canada (CA), Occupational Cancer Research Centre (CA), Université Laval (CA), Hotchkiss Brain Institute (CA), McGill University (CA), Université de Montréal (CA)
Openalex Percentile: Top 47%
Amyotrophic Lateral Sclerosis Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.